Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.
Year: 2002
Type: article
Source: PubMed
Authors: John M L Ebos, Jennifer Tran, Zubin Master, Daniel Dumont, Junia V Melo, Elisabeth Buchdunger, Robert S Kerbel
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2186650217
